DV Biomed Co. Ltd.
DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and China. The company provides health and slimming services; and distributes medical aesthetic fillers and aesthetic medical equipment. It also offers functional beverages and supplements, including beauty, slimming, supplements, and other products; skin care; and beauty products and services. The company was f… Read more
DV Biomed Co. Ltd. (6539) - Total Liabilities
Latest total liabilities as of June 2025: NT$183.69 Million TWD
Based on the latest financial reports, DV Biomed Co. Ltd. (6539) has total liabilities worth NT$183.69 Million TWD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
DV Biomed Co. Ltd. - Total Liabilities Trend (2019–2024)
This chart illustrates how DV Biomed Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
DV Biomed Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of DV Biomed Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Know Labs Inc.
NYSE MKT:KNW
|
USA | $5.28 Million |
|
Sejin T.S Co.Ltd
KQ:067770
|
Korea | ₩1.08 Billion |
|
Trustfeed Corp
PINK:TRFE
|
USA | $977.38K |
|
Hitek Global Inc. Ordinary Share
NASDAQ:HKIT
|
USA | $7.67 Million |
|
Revenue Group Bhd
KLSE:0200
|
Malaysia | RM92.63 Million |
|
Federal Life Group Inc
PINK:FLFG
|
USA | $232.76 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down DV Biomed Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.36 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how DV Biomed Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for DV Biomed Co. Ltd. (2019–2024)
The table below shows the annual total liabilities of DV Biomed Co. Ltd. from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$243.01 Million | +104.54% |
| 2023-12-31 | NT$118.81 Million | -37.91% |
| 2022-12-31 | NT$191.36 Million | -72.03% |
| 2021-12-31 | NT$684.25 Million | +9.71% |
| 2020-12-31 | NT$623.71 Million | -18.08% |
| 2019-12-31 | NT$761.36 Million | -- |